News

Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone

View more

Jul 30, 2026

Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs

View more

Jul 29, 2026

SPECT/CT viable over PET/CT for high-risk prostate cancer staging

View more

Jul 29, 2026

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

View more

Jul 24, 2026

Novartis scraps mid-stage radiopharma asset as Pluvicto soars

View more

Jul 24, 2026

Lutetium-177 PSMA-617 shows promise in earlier-stage prostate cancer

View more

Jul 23, 2026